Cell & Gene Therapy · Health Care
GentiBio news and milestones
GentiBio: 6 headlines on record, 1 headline in the last 90 days. Its story counts 4 milestones.
Data updated Nov 17, 2026 · Back to the company report
6Headlines
1In 90 days
4Milestones
Headlines
Sep 252026
News · pharmaphorum
Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD). The deal includes an…
Mar 182026
Press release · PRNewswire
/PRNewswire/ -- GentiBio, Inc., a clinical-stage biotechnology company pioneering engineered, antigen-specific regulatory T cell (EngTreg) therapies, today...
Mar 22, 20242024
Mar 7, 20242024
Aug 10, 20222022
News · bizjournals.com
Aug 11, 20212021
Sources: the outlets named on each headline, each story once
Milestones
Aug 15, 2025
Aug 10, 2022
Aug 10, 2021
Each milestone is dated by its source: registers, filings, the press
How to cite
GentiBio, News. Alion, Nov 17, 2026. https://alion.io/company/gentibio/news
